TINAVI MEDICAL TECHNOLOGIES CO.,LTD. Tinavi Medical Technologies Co.,Ltd. Stock
Equities
688277
CNE100004256
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.72 CNY | +4.18% |
|
+12.37% | -33.84% |
| Sales 2022 | 156M 21.56M 29.47M | Sales 2023 | 210M 28.99M 39.63M | Capitalization | 5.92B 817M 1.12B |
|---|---|---|---|---|---|
| Net income 2022 | -111M -15.32M -20.94M | Net income 2023 | -156M -21.53M -29.43M | EV / Sales 2022 | 31 x |
| Net cash position 2022 | 153M 21.14M 28.9M | Net cash position 2023 | 141M 19.46M 26.6M | EV / Sales 2023 | 27.5 x |
| P/E ratio 2022 |
-45.7
x | P/E ratio 2023 |
-37.7
x | Employees | 362 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.18% | ||
| 1 week | +12.37% | ||
| Current month | -7.23% | ||
| 1 month | -8.40% | ||
| 3 months | -20.51% | ||
| 6 months | -34.19% | ||
| Current year | -33.84% |
1 week
7.66
8.73
1 month
7.669.65
Current year
7.5013.46
1 year
7.5019.78
3 years
7.5044.76
5 years
7.50141.60
10 years
7.50141.60
| Managers | Title | Age | Since |
|---|---|---|---|
Jin Xu
CEO | Chief Executive Officer | 50 | 14-08-31 |
Song Gen Zhang
FOU | Founder | 58 | 10-10-21 |
Min Qi
DFI | Director of Finance/CFO | 42 | 11-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yang Xu
BRD | Director/Board Member | 57 | 23-09-06 |
Song Gen Zhang
FOU | Founder | 58 | 10-10-21 |
De Quan Zhu
BRD | Director/Board Member | 59 | 10-09-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 8.72 | +4.18% | 3,970,819 |
| 24-04-25 | 8.37 | +1.58% | 3,298,645 |
| 24-04-24 | 8.24 | +1.48% | 2,191,383 |
| 24-04-23 | 8.12 | +1.88% | 2,739,547 |
| 24-04-22 | 7.97 | +2.71% | 3,729,251 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes
Tinavi Medical Technologies Co Ltd is a China-based company mainly engaged in the research, development, production, sales and service of orthopedic surgery navigation and positioning robots. The Company's products and services for medical institutions mainly include orthopedic surgery navigation and positioning robots, GD-A, GD-2000/GD-S and TiRobot, surgery center professional engineering, supporting equipment and consumables and technology services. The Company mainly conducts its businesses within the domestic market.
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -33.84% | 541M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B | |
| +26.76% | 32.03B |
- Stock Market
- Equities
- 688277 Stock
